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1.  Introduction
Cordyceps is a stroma of the fungus that exists as a 
composite parasite on the larva of some insects 
and the dead caterpillars. It is sweet in taste and 
neutral in nature, acting on the Lung and Kidney 
meridians, and has the effects of reinforcing the 
lung and the kidney, arresting bleeding, and dis-
pelling phlegm. Cordyceps has been used in chronic 
cough and asthma, hemoptysis in phthisis, impo-
tence and emissions, aching of loins and knees [1], 
and contains five main nutrients and trace elements 
such as cordycepin, cordycepic acid, ophiocordin, 
glucan and complex polysaccharides. Studies inves-
tigating active ingredients are still proceeding [2].
Cordyceps militaris, a species of Cordyceps, is na-
tive to Korea. C. militaris contains large amounts of 
cordycepin and is known to have antibacterial, antitu-
mor, immune-enhancing and addiction-detoxification 
effects [3]. Global attention on C. militaris has been 
increasing given its antitumor and immune enhancing 
activity. Ergosterol peroxide extracted from C. mil-
itaris has shown a strong activity against a Korean 
gastric cancer cell line in vitro [4]. Furthermore, 
water soluble fraction of C. militaris showed cyto-
toxic activity on three kinds of human cancer cell 
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lines: stomachic adenocarcinoma, colorectal ade-
nocarcinoma, and hepatocellular carcinoma. The 
presumed active component in the extract was 
cordycepin [5]. One study, however, has suggested 
that many ingredients in C. militaris have a stronger 
antitumor effect compared with cordycepin [2]. 
Recently, an in vitro assay to determine the antitu-
mor mechanism of C. militaris reported that apop-
totic events in A549 cells due to water extract of 
C. militaris were mediated via diminished telom-
erase activity through the inhibition of human 
telomerase reverse transcriptase transcriptional 
activity [6].
Base on these results, we performed an in vivo 
trial to evaluate the antitumor effect of admin-
istration of water extracts from C. militaris to lung 
cancer xenografted mice. We measured the volume 
of xenografted tumor, weight of each organ and 
survival time of mice. Cells were also inspected 
to determine if there was any kind of pathologic 
change.
2.  Materials and Methods
2.1.  Cell line and culture conditions
Human lung cancer (NCI-H460) cells were obtained 
from the Korean Cell Line Bank (Seoul, Korea). The 
cells were grown in RPMI-1640 medium (Gibco, 
USA) supplemented with 10% fetal bovine serum, 
100 U/mL penicillin and 100 mg/mL streptomycin 
in an incubator with 5% CO2 at 37°C. When the cells 
became confluent, they were washed twice with 
Hank’s balanced salt solution (HBSS), trypsinized 
with 0.25% trypsin in HBSS and subsequently washed 
twice with fresh culture medium [7].
2.2.  Experimental animals
Balb/c nude mice (male, 9−11 weeks, n = 21) weigh-
ing 21−25 g were purchased from Japan SLC, Inc. 
(Shizuoka, Japan) and were housed under specific 
pathogen-free conditions according to the guide-
lines of Chungbuk National University Animal Care 
and Use Committee. The animal room was control-
led for temperature (22 ± 2°C), light (12 hour light/
dark cycle) and humidity (50 ± 10%). All laboratory 
feed pellets and bedding was autoclaved.
2.3.  Experimental design
The tumor regression model in nude mice has been 
successfully applied to evaluate antitumor activity 
[8]. This model was therefore used to evaluate sup-
pression of solid tumor growth in water extracts of 
C. militaris (WECM). When the tumor volume reached 
100 mm3 in the nude mice, xenografted tumor frag-
ments were randomly distributed into three groups: 
NCI-H460 + saline only (control group), NCI-H460 + 
150 mg/kg/day WECM-treated group, and NCI-H460 + 
300 mg/kg/day WECM-treated group. Seven mice 
were included in each group. WECM was orally 
administrated daily for 4 weeks.
2.4. Xenografts
A total of 1 ˜  106 NCI-H460 cells in 0.1 mL HBSS 
were injected subcutaneously into the flank of each 
mouse using a 26-gauge needle. After 16 days obser-
vation, an apparently solid tumor mass was excised 
from three of five mice inoculated with NCI-H460 
cells. Tumor fragments (3 ˜  3 ˜  3 mm) were created 
by trimming with a knife, and xenografted into the 
flank of new mice using a trocar. The suppressive 
effect of anticancer agents on solid tumor was eval-
uated in a tumor-regression model. In brief, from 
the day tumor volume reached 100 mm3, the mice 
xenografted with a tumor fragment received orally 
administered WECM (saline, 150 mg or 300 mg/kg) 
every day.
2.5.  Changes in tumor volume
The sizes of tumor mass were recorded twice a 
week following measurement with a digital cali-
per. The tumor volume was estimated according to 
the formula:
Vtumor = (A ˜  B2)/2
Vmean is the mean tumor volume in mm3, A is 
the largest tumor diameter and B is the smallest 
tumor diameter in mm.
Based on the regression of tumor volume, the 
antitumor activities of treatment were expressed 
by inhibition rate:
Inhibition rate (%)
= [(Vcontrol − Vtreatment)/Vtreatment] ˜  100
Vcontrol and Vtreatment are tumor volume of con-
trol group and treatment respectively. The tumor 
weights were also measured on the final day of the 
experiment after sacrifice of animals and excision 
of the tumor mass.
2.6.  Mean survival time and percentage 
increase in lifespan
To compare the lifespan of mice xenografted with 
NCI-H460 tumor fragments, mean survival time 
was estimated from the day when the tumor vol-
ume reached 1000 mm3 as described previously, and 
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percentage increase in lifespan (%ILS) was calcu-
lated according to the equation:
%ILS = [(Dtreatment − Dcontrol)/Dcontrol] ˜  100
Dcontrol and Dtreatment are the mean survival day 
of mice in control and treatment group, respec-
tively [9,10].
2.7.  Statistical analysis
The results are presented as mean ± standard devi-
ation, and the significance of difference between 
the mean of control and treatment groups was an-
alyzed using one-way analysis of variance (ANOVA) 
followed by a Dunnett’s t test correction, paired 
t test, and linear regression analysis. Statis tical 
significance was determined at the level of p < 0.05 
and p < 0.01.
3.  Results
3.1.  Changes in body weight
Changes in body weight of each group are shown in 
Figure 1. The mean body weights were 23.67−
25.89 g in the 150 mg/kg/day WECM-treated group 
and 24.24−25.99 g in the 300 mg/kg/day WECM-
treated group. But there were no significant dif-
ferences when compared with the control group 
(24.10−26.43 g).
3.2.  Changes in tumor volume
As shown in Figure 2, WECM treatment (150 and 
300 mg/kg/day) resulted in slight growth inhibition 
of NCI-H460 cell-transplanted solid tumor com-
pared with the control group, but there were no 
significant difference. On day 22, the mean tumor 
volume of the 300 mg/kg/day WECM-treated group 
(1771.5 mm3) was lower than that of control group 
(2150.81 mm3), but there were no significant inter-
group difference.
3.3.  Inhibition rate (IR) on tumor volume
The IR of each group is shown in Table 1. In the 
whole experiment, the IR of the 150 mg/kg/day 
WECM-treated group was 94.73−75.08% and that 
of the 300 mg/kg/day WECM-treated group was 
85.81−73.81%.
3.4.  Final tumor weights and volume
Tumor weights and volumes of each group on day 
22 are shown in Table 2. Tumor weight and volume 
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Figure 1 Changes in body weights of nude mice bearing 
NCI-H460 tumors under treatment with water extracts 
of Cordyceps militaris (WECM).
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Figure 2 Changes in tumor volume of nude mice treated 
with water extracts of Cordyceps militaris (WECM). 
of the control group was 3.046 ± 0.793 g and 3.379 ± 
1.184 cm3, respectively. Tumor weight and volume 
of 150 mg/kg/day WECM-treated group were 2.435 ± 
0.586 g and 2.288 ± 0.510 cm3, respectively. Tumor 
weight and volume of 300 mg/kg/day WECM-treated 
group were 2.175 ± 0.475 g and 2.069 ± 0.440 cm3, 
respectively. Compared with the control group, both 
tumor weight and volume of in two WECM-treated 
groups were decreased. The 300 mg/kg/day WECM-
treated group showed significant decrease compared 
with control group (p < 0.05; Table 2).
3.5.  Mean survival time and %ILS
Mean survival time and %ILS are shown in Figure 3 
and Table 3. The mean survive time of control 
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group was 18.43 ± 2.23 days. The mean survival 
time of the 150 mg/kg/day WECM-treated group 
was extended to 19.43 ± 2.44 days, increasing %ILS 
by 5.42%. The mean survival time of 300 mg/kg/day 
WECM-treated group was 21.86 ± 3.53 days, increas-
ing %ILS by 18.61%. However, the difference were 
not statistically significant.
3.6.  Histopathological findings and 
organ weights
Absolute organ weights of the kidney, liver, spleen, 
heart and lung are shown Table 4. Both the 150 
and 300 mg/kg/day WECM-treated groups showed a 
marked decrease in liver weights (p < 0.05). However, 
light microscopic histopathological examination 
showed no specific lesion in liver tissue of mice in 
neither WECM-treated groups nor control group 
(Figure 4).
4.  Discussion
C. militaris is well known to contain cordycepin and 
ergosterol peroxide, two ingredients with antitu-
mor effects [4]. Cordycepin was reported to be 3-
deoxyadenosine, a derivative of adenine, which 
could have antitumor effects by replacing adenine 
in DNA and RNA [10]. Ergosterol peroxide is re-
ported to exhibit cytotoxic activities against tumor 
cells [11].
Table 1 Inhibition rate on tumor volume in NCI-H460 tumor-bearing mice*
Treatment 1 d 5 d 8 d 12 d 15 d 19 d 22 d
Saline 100 100 100 100 100 100 100
WECM
  150 mg/kg/day 95.13 94.73 75.08 80.23 86.06 90.55 89.10
  300 mg/kg/day 94.03 88.00 73.81 80.65 85.81 84.50 82.36
*Data presented as %. WECM = water extracts of Cordyceps militaris.
Table 2 Tumor weights in mice xenografted with NCI-
H460 cells on day 22*
Treatment 
Tumor Tumor
 weight (g) volume (cm3)
Saline 3.046 ± 0.793 3.379 ± 1.184
WECM
  150 mg/kg/day 2.435 ± 0.580 2.288 ± 0.510
  300 mg/kg/day 2.175 ± 0.475† 2.069 ± 0.440†
*Data presented as mean ± standard deviation; †Statistical 
significant defined as p < 0.05 as compared to control saline 
group. WECM = water extracts of Cordyceps militaris.
Table 3 Percentage increase in lifespan (% ILS) of 
NCI-H460 tumor-bearing mice 
Treatment Mean survival time (d) % ILS
Saline 18.43 ± 2.23 0
WECM
  150 mg/kg/day 19.43 ± 2.44  5.42
  300 mg/kg/day 21.86 ± 3.53 18.61
WECM = water extracts of Cordyceps militaris.
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Figure 3 Mean survival time in NCI-H460 tumor-bearing 
mice treated with water extracts of Cordyceps militaris 
(WECM).
However, clinicians in the East have practiced 
using whole C. militaris, the evaluation of the anti-
tumor effect of whole C. militaris would be more 
practical. To this end, an assay showing that water 
extract of C. militaris induced apoptosis and inhi-
bited telomerase activity in human lung carcinoma 
cells has been published [6]. This activity occurred 
by activating the intrinsic caspase pathway along 
with the death receptor-mediated extrinsic pathway 
and was associated with a down regulation of telom-
erase activity due to a decrease of human telom-
erase reverse transcriptase expression [6].
Human tumor xenografts in immunodeficient 
animal models provided a means to evaluate po-
tential antitumor drugs in preclinical studies and 
are applicable for studying many different types of 
human malignancies [12]. Thus we also conducted 
an in vivo experiment on nude mice with NCI-H460 
cell-xenografted tumor for 28 days. These tumors 
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were treated with WECM (150 and 300 mg/kg/day). 
Time-dependent changes of tumor volume were 
measured and excised tumor volume was measured 
on the final day. Results showed that the tumors 
were suppressed by WECM treatment but did not 
shrink in a dose-dependent manner.
WECM inhibited the NCI-H460 tumor growth in 
nude mice throughout the experimental period. 
WECM treatment (150 and 300 mg/kg/day) pro-
longed the mean survival time and increased %ILS 
compared with the control group. The survival 
time of the 150 mg/kg/day WECM treatment group 
was extended to an average of 19.43 ± 2.44 days 
and increased %ILS by 5.42%. Also, the mean sur-
vival time of the 300 mg/kg/day WECM treatment 
group was 21.86 ± 3.53 days, an 18.61% increase in 
%ILS. Intraperitoneal injection of C. militaris ex-
tracts into ICR mice bearing at least 180 sarcoma 
cells was shown to prolong the lifespan of mice 
from 52.4 to 132% [2]. Findings from this study and 
previous results are similar in that the lifespan of 
mice was increased even though the methods were 
different. However, the difference in lifespan exten-
sion between two studies may indicate that differ-
ent administration methods could cause differences 
in efficacy.
The results showed that WECM inhibited the 
growth of NCI-H460 cell-transplanted solid tumor. 
Compared with the control group, the treatment 
group showed tumor growth inhibition from day 8 
to day 22. However, this trend was not significant 
statistically. On day 22, the volume of the solid 
tumor was 2.069 ± 0.440 cm3 in the 300 mg/kg/day 
WECM-treated group and 3.3379 ± 1.184 cm3 in the 
control group. Tumor weights were 2.175 ± 0.475 g 
in the 300 mg/kg/day WECM-treated group), 2.435 ± 
0.58 g in the 150 mg/kg/day WECM-treated group 
and 3.046 ± 0.793 g in the control group (Table 2). 
Previously, an in vitro study demonstrated that an 
ethanol extract of C. militaris produced an inhi-
bitory effect of up to 65.5% in A549 human lung 
cancer cells [13], indicating that C. militaris may 
inhibit cancer growth. Numerical differences be-
tween this pervious study and the present data may 
be due to the differences in methodology (in vitro 
vs. in vivo) and extraction technique (ethanol vs. 
water). The underlying reasons for these differences 
should be elucidated to allow further exploitation 
of the use of C. militaris in clinical practice.
There were no differences in body weight, gross 
toxicity and organ weight between WECM-treated 
group and control group. There was no significant 
change in absolute organ weights, except in the 
liver. The results of in vivo studies implied that 
WECM may have potential as a growth inhibitor of 
solid tumor induced NCI-H460 without marked side 
effects. These results suggest that WECM may have 
the possibility to be a useful anticancer agent for 
therapy in human lung cancer.
Most of the results of this study indicate that 
WECM shows an antitumor effect in animal models 
but some are not significant. Although no significant 
pathologic changes in liver tissue were observed, 
the reasons for increasing relative liver weight needs 
to be further investigated.
In summary, this study showed that WECM may 
suppress the growth of a human lung cancer cell 
mass and increase the lifespan of nude mice. Results 
of this trial may stimulate more studies into WECM 
to determine its clinical use in cancer patients.
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